Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Cancer Investigation|August 31, 2006
Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancerFaruk Tas, Derya Duranyildiz, Hilal Oguz, et al.Tumori|July 27, 2011
Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancerEsra Ertan, Hilal Soydinc, Aziz Yazar, et al.Cancer Investigation|September 20, 2006
Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancerFaruk Tas, Derya Duranyildiz, Hilal Oguz, et al.Cancer Investigation|December 7, 2007
Macrophage migration inhibitory factor in cancerVildan Yasasever, Hakan Camlica, Derya Duranyildiz, et al.Journal of the Turkish German Gynecological Association|March 5, 2014
Determination of serum CRP, VEGF, Leptin, CK-MB, CA-15-3 and IL-6 levels for malignancy prediction in adnexal massesSerhat Sen, Oğuzhan Kuru, Ozgür Akbayır, et al.Medical Oncology (Northwood, London, England)|January 22, 2008
Effect of zoledronic acid on serum angiogenic factors in patients with bone metastasesFaruk Tas, Derya Duranyildiz, Hilal Oguz, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 21, 2014
EMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective studyElif Bilgin Doğru, Yavuz Dizdar, Ece Akşit, et al.Medical Oncology (Northwood, London, England)|November 2, 2005
Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancerFaruk Tas, Derya Duranyildiz, Andac Argon, et al.American Journal of Clinical Oncology|June 1, 2004
Clinical value of protein S100 and melanoma-inhibitory activity (MIA) in malignant melanomaFaruk Tas, Vildan Yasasever, Derya Duranyildiz, et al.Medical Oncology (Northwood, London, England)|August 20, 2005
The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanomaFaruk Tas, Hilal Oguz, Andaç Argon, et al.Pageof 4